AZD5904 is primarily explored for its potential therapeutic applications in the treatment of neurodegenerative diseases, particularly those involving oxidative stress and mitochondrial dysfunction. Its mechanism of action targets specific pathways that help protect neurons from damage, making it a candidate for conditions like Parkinson's disease and Alzheimer's disease. Researchers are investigating its efficacy in reducing neuronal degeneration and improving cognitive and motor functions in preclinical models. Additionally, its potential to modulate oxidative stress responses could extend its use to other conditions where oxidative damage plays a critical role. Clinical studies are ongoing to evaluate its safety, tolerability, and effectiveness in humans.